Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
41 hedge funds and large institutions have $17.6M invested in Enzo Biochem, Inc. in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 10 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5.41% less ownership
Funds ownership: 32.39% → 26.98% (-5.4%)
11% less funds holding
Funds holding: 46 → 41 (-5)
23% less capital invested
Capital invested by funds: $22.7M → $17.6M (-$5.18M)
40% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 10
73% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$32.1K |
| 2 |
PI
PFG Investments
Woodbury,
New York
|
+$24.6K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$19.2K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.06K |
| 5 |
BL
BFSG LLC
Irvine,
California
|
+$3.71K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$581K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$321K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$105K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$97.6K |
| 5 |
Lazard Asset Management
New York
|
-$70K |
ENZ Hedge Fund Activity: Q1 2024 in Review
41 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2024, worth a combined $17.6M — down 23% from $22.7M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of ENZ and 6 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 3 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $32.1K. The largest seller was Tang Capital Management, cutting an estimated $581K.
- 41 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2024, down from 46 in Q4 2023.
- Funds reported $17.6M of Enzo Biochem, Inc. stock for Q1 2024, down 23% quarter-over-quarter.
- 6 funds opened new Enzo Biochem, Inc. positions in Q1 2024 and 10 closed out, a net change of -4 holders.
- The largest Enzo Biochem, Inc. buyer in Q1 2024 was Susquehanna International Group, an estimated $32.1K added.
- The largest Enzo Biochem, Inc. seller in Q1 2024 was Tang Capital Management, an estimated $581K sold.
Based on aggregated 13F filings for Q1 2024.